Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Most Famous Virtual Entertainment Powerhouses of the Year - 2Motivational Travel Objections for History Buffs
- 3Careful Nurturing: Techniques for Bringing up Tough Children
- 4Figure out How to Consolidate Cutting edge innovations in Senior's SUVs
- 5Taste the World: Five Food sources That Have Dazzled Worldwide Palates
- These 45 exoplanets may be the best places to search for alien life
- IDF kills four terrorists equipped with weapons, surveillance gear near Gaza's Yellow Line
- I visited the largest collection of public telescopes in the US in Oregon's high desert, and the dark skies blew me away
- The breakout star of NASA's Artemis 2 moon mission isn't an astronaut — it's the space toilet
- Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
- Interstellar comet 3I/ATLAS' journey through our solar system, in photos
- Make Your Fantasy Closet: 10 Immortal Design Fundamentals
- Doulas play essential roles in reproductive health care – and more states are beginning to recognize it
- 7 Strange Apparatuses to Make Your Party Stick Out!
